Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-024699

SVP, Chief Accounting Officer sold 132 shares at $84.55 ($11,161)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-04-16 Sale : show line 1 in the form −132 $84.55 $11,161 16,914 D
Open-market sales · 132 sh · avg $84.55 · $11,161
Loading xslF345X03/doc4.xml…